发明名称 |
Therapeutical method for the treatment of the Leber optic neuropathy |
摘要 |
It is described the use of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, for the preparation of a medicament or a nutritional supplement useful for preventing or treating the Leber optic neuropathy. |
申请公布号 |
US9114120(B2) |
申请公布日期 |
2015.08.25 |
申请号 |
US201113988557 |
申请日期 |
2011.09.09 |
申请人 |
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P.A. |
发明人 |
Cavazza Claudio;Koverech Aleardo;D'Iddio Stefania |
分类号 |
A61K31/221;A23L1/305;A61K31/205;A61K45/06 |
主分类号 |
A61K31/221 |
代理机构 |
Lucas & Mercanti, LLP |
代理人 |
Lucas & Mercanti, LLP |
主权项 |
1. Method for treating the Leber optic neuropathy, said method comprising orally administering to a patient suffering from Leber optic neuropathy an amount of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, administered orally in a dose of 0.5-4 g/day, in a single or divided dose for 12 months, to treat the Leber optic neuropathy in said patient. |
地址 |
Rome IT |